In contrast, the CB-derived cell line with KMT2A::MLLT1 demonstrated comparably high SMAD1 levels, consistent with findings in primary T-ALL patient cells with KMT2A::MLLT1 (47) (Figures 1D, E). The gene discussed is SMAD1; the disease is acute lymphoblastic leukemia.